Piramal Life Sciences Limited has informed the Exchange regarding a press release dated August 25, 2009, titled "Piramal Life Sciences completes Phase I Trials with a New Molecule for Type II Diabetes in Europe". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).
| NIFTY 
